athenahealth, Inc. Reports First Quarter Fiscal Year 2017 Results

Go back to athenahealth, Inc. Reports First Quarter Fiscal Year 2017 Results

athenahealth (ATHN) PT Lowered to $123 at UBS

May 1, 2017 10:08 AM EDT

UBS lowered its price target on athenahealth (NASDAQ: ATHN) to $123.00 (from $140.00) while maintaining a Buy rating.

UBS reduced revenue estimates, with FY17 revenues down from $1.29Bn to $1.22Bn and FY18 revenues down from $1.50Bn to $1.41Bn. FY17 EPS was also reduced from $2.44 to $2.12 and FY18 EPS from $3.05 to $2.56.

... More

athenahealth (ATHN) PT Lowered to $118 at Cantor Fitzgerald Following 1Q

April 28, 2017 11:13 AM EDT

Cantor Fitzgerald lowered its price target on athenahealth (NASDAQ: ATHN) to $118.00 (from $135.00) while maintaining a Overweight rating. 1Q17 revenue was $285 million vs. estimates of $300 million. Revenue grew 11% year over year. Adjusted EPS was $0.32 vs. FactSet consensus of $0.46.

Bookings are now expected to be $350-400... More

Athenahealth (ATHN) Misses Q1 EPS by 15c; Lowers Outlook

April 27, 2017 4:03 PM EDT

Athenahealth (NASDAQ: ATHN) reported Q1 EPS of $0.32, $0.15 worse than the analyst estimate of $0.47. Revenue for the quarter came in at $285.4 million versus the consensus estimate of $297.56 million.

Based on the... More